 Rachel Frank
Concepts (852)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 58 | 2025 | 268 | 9.480 |
Why?
| | Shoulder Joint | 50 | 2024 | 199 | 8.990 |
Why?
| | Joint Instability | 36 | 2024 | 187 | 8.420 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 21 | 2026 | 193 | 5.640 |
Why?
| | Cartilage, Articular | 24 | 2026 | 349 | 4.980 |
Why?
| | Anterior Cruciate Ligament Injuries | 21 | 2026 | 217 | 4.730 |
Why?
| | Knee Joint | 31 | 2026 | 439 | 4.500 |
Why?
| | Knee Injuries | 18 | 2022 | 121 | 4.390 |
Why?
| | Sports Medicine | 12 | 2026 | 120 | 4.390 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 62 | 4.330 |
Why?
| | Shoulder Dislocation | 17 | 2026 | 61 | 4.160 |
Why?
| | Biological Products | 12 | 2024 | 257 | 4.140 |
Why?
| | Tibia | 14 | 2025 | 177 | 4.050 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 252 | 4.040 |
Why?
| | Platelet-Rich Plasma | 14 | 2026 | 41 | 3.970 |
Why?
| | Menisci, Tibial | 17 | 2025 | 78 | 3.860 |
Why?
| | Athletic Injuries | 23 | 2026 | 574 | 3.800 |
Why?
| | Orthopedics | 13 | 2026 | 181 | 3.730 |
Why?
| | Rotator Cuff Injuries | 13 | 2026 | 79 | 3.460 |
Why?
| | Bone Transplantation | 14 | 2025 | 89 | 3.360 |
Why?
| | Osteotomy | 12 | 2025 | 129 | 3.190 |
Why?
| | Osteoarthritis, Knee | 18 | 2026 | 284 | 3.000 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.780 |
Why?
| | Simulation Training | 6 | 2024 | 136 | 2.720 |
Why?
| | Hip Joint | 8 | 2018 | 172 | 2.260 |
Why?
| | Tenodesis | 8 | 2020 | 20 | 2.230 |
Why?
| | Cartilage Diseases | 5 | 2019 | 45 | 2.200 |
Why?
| | Arthroplasty, Replacement, Knee | 9 | 2025 | 383 | 2.130 |
Why?
| | Arthroplasty | 10 | 2020 | 60 | 2.120 |
Why?
| | Reoperation | 29 | 2023 | 633 | 2.080 |
Why?
| | Meniscus | 4 | 2023 | 23 | 2.010 |
Why?
| | Humans | 312 | 2026 | 145625 | 1.940 |
Why?
| | Allografts | 19 | 2025 | 148 | 1.920 |
Why?
| | Rotator Cuff | 9 | 2026 | 61 | 1.890 |
Why?
| | Shoulder Injuries | 9 | 2024 | 66 | 1.860 |
Why?
| | Tendons | 11 | 2026 | 134 | 1.690 |
Why?
| | Shoulder | 22 | 2023 | 105 | 1.680 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 41 | 1.620 |
Why?
| | Return to Sport | 10 | 2025 | 117 | 1.620 |
Why?
| | Cartilage | 10 | 2025 | 197 | 1.600 |
Why?
| | Computer Simulation | 6 | 2021 | 1014 | 1.600 |
Why?
| | Postoperative Complications | 25 | 2026 | 2962 | 1.600 |
Why?
| | Transplantation, Homologous | 19 | 2025 | 415 | 1.580 |
Why?
| | Sports | 7 | 2023 | 216 | 1.550 |
Why?
| | Patient Reported Outcome Measures | 11 | 2026 | 502 | 1.480 |
Why?
| | Suture Anchors | 7 | 2021 | 35 | 1.450 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 94 | 1.410 |
Why?
| | Scapula | 11 | 2023 | 48 | 1.410 |
Why?
| | Athletes | 7 | 2023 | 430 | 1.410 |
Why?
| | Internship and Residency | 9 | 2026 | 1269 | 1.400 |
Why?
| | Clinical Competence | 8 | 2024 | 1261 | 1.400 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 12 | 1.400 |
Why?
| | Tendon Injuries | 5 | 2019 | 73 | 1.310 |
Why?
| | Adult | 132 | 2026 | 40821 | 1.260 |
Why?
| | Young Adult | 53 | 2026 | 14240 | 1.170 |
Why?
| | Treatment Outcome | 51 | 2026 | 11744 | 1.160 |
Why?
| | Second-Look Surgery | 3 | 2025 | 8 | 1.150 |
Why?
| | Femur | 9 | 2025 | 261 | 1.150 |
Why?
| | Male | 166 | 2026 | 73014 | 1.110 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 727 | 1.070 |
Why?
| | Humeral Head | 7 | 2023 | 21 | 1.070 |
Why?
| | Female | 161 | 2026 | 79080 | 1.070 |
Why?
| | Bankart Lesions | 4 | 2023 | 11 | 1.050 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.040 |
Why?
| | Quadriceps Muscle | 3 | 2026 | 120 | 1.010 |
Why?
| | Biomechanical Phenomena | 18 | 2026 | 868 | 1.010 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 101 | 1.010 |
Why?
| | Middle Aged | 106 | 2026 | 36359 | 0.980 |
Why?
| | Bone Malalignment | 2 | 2025 | 12 | 0.970 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 3 | 0.960 |
Why?
| | Joint Dislocations | 2 | 2024 | 60 | 0.950 |
Why?
| | Bone Screws | 5 | 2020 | 115 | 0.950 |
Why?
| | Ligaments, Articular | 5 | 2023 | 56 | 0.950 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 10 | 0.920 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 566 | 0.910 |
Why?
| | Osteoarthritis | 7 | 2019 | 204 | 0.900 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 437 | 0.890 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 30 | 0.870 |
Why?
| | Achilles Tendon | 2 | 2023 | 37 | 0.840 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5397 | 0.820 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 116 | 0.790 |
Why?
| | Adolescent | 77 | 2025 | 22451 | 0.780 |
Why?
| | Cadaver | 13 | 2020 | 302 | 0.770 |
Why?
| | Social Media | 2 | 2024 | 158 | 0.750 |
Why?
| | Brain Concussion | 5 | 2025 | 660 | 0.710 |
Why?
| | Venous Thrombosis | 2 | 2022 | 195 | 0.700 |
Why?
| | Lacerations | 1 | 2022 | 38 | 0.690 |
Why?
| | Retrospective Studies | 57 | 2025 | 17291 | 0.690 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 187 | 0.690 |
Why?
| | Pain | 6 | 2018 | 787 | 0.680 |
Why?
| | Bone Resorption | 3 | 2018 | 80 | 0.640 |
Why?
| | Golf | 1 | 2020 | 9 | 0.640 |
Why?
| | Rupture | 8 | 2023 | 90 | 0.630 |
Why?
| | Hypertension | 12 | 2025 | 1270 | 0.630 |
Why?
| | Skiing | 1 | 2021 | 50 | 0.620 |
Why?
| | Radiography | 16 | 2019 | 856 | 0.620 |
Why?
| | Suture Techniques | 8 | 2019 | 137 | 0.600 |
Why?
| | Hamstring Muscles | 2 | 2018 | 22 | 0.600 |
Why?
| | Internet | 3 | 2022 | 656 | 0.590 |
Why?
| | Physical Examination | 9 | 2018 | 236 | 0.580 |
Why?
| | Humerus | 7 | 2020 | 40 | 0.570 |
Why?
| | Aged | 72 | 2025 | 26251 | 0.570 |
Why?
| | Stress, Mechanical | 4 | 2026 | 493 | 0.550 |
Why?
| | Kidney Transplantation | 6 | 2024 | 702 | 0.540 |
Why?
| | Prosthesis Failure | 5 | 2015 | 125 | 0.540 |
Why?
| | Swimming | 1 | 2018 | 54 | 0.540 |
Why?
| | Tenotomy | 1 | 2018 | 22 | 0.530 |
Why?
| | Yoga | 1 | 2018 | 31 | 0.520 |
Why?
| | Virtual Reality | 1 | 2019 | 82 | 0.520 |
Why?
| | Adipose Tissue | 6 | 2025 | 641 | 0.520 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 229 | 0.520 |
Why?
| | Glenoid Cavity | 2 | 2015 | 9 | 0.520 |
Why?
| | Treatment Failure | 6 | 2020 | 358 | 0.520 |
Why?
| | Facial Recognition | 1 | 2018 | 29 | 0.520 |
Why?
| | Meniscectomy | 3 | 2025 | 18 | 0.520 |
Why?
| | Leg Injuries | 1 | 2017 | 24 | 0.520 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 330 | 0.520 |
Why?
| | Bone Density | 2 | 2021 | 492 | 0.510 |
Why?
| | Facial Expression | 1 | 2018 | 65 | 0.510 |
Why?
| | Fractures, Stress | 1 | 2017 | 31 | 0.510 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 578 | 0.510 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.500 |
Why?
| | Bundle of His | 1 | 2017 | 19 | 0.500 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 99 | 0.500 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 30 | 0.490 |
Why?
| | Fractures, Ununited | 1 | 2017 | 28 | 0.490 |
Why?
| | Ulna Fractures | 1 | 2017 | 16 | 0.490 |
Why?
| | Transplantation, Autologous | 7 | 2026 | 303 | 0.490 |
Why?
| | Social Perception | 1 | 2018 | 101 | 0.490 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 30 | 0.490 |
Why?
| | Bicycling | 1 | 2017 | 117 | 0.490 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 61 | 0.490 |
Why?
| | Hip | 3 | 2014 | 57 | 0.490 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1795 | 0.490 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 59 | 0.490 |
Why?
| | Atrioventricular Block | 1 | 2017 | 44 | 0.480 |
Why?
| | Chondrocytes | 2 | 2018 | 232 | 0.480 |
Why?
| | Databases, Factual | 10 | 2019 | 1481 | 0.480 |
Why?
| | Ozone | 4 | 2001 | 116 | 0.470 |
Why?
| | Sex Factors | 8 | 2026 | 2101 | 0.460 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 417 | 0.460 |
Why?
| | Incidence | 13 | 2025 | 2910 | 0.450 |
Why?
| | Osteosarcoma | 2 | 2015 | 100 | 0.450 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 35 | 0.450 |
Why?
| | Magnetic Resonance Imaging | 8 | 2026 | 3917 | 0.450 |
Why?
| | Patellar Ligament | 2 | 2014 | 27 | 0.450 |
Why?
| | Risk Factors | 25 | 2025 | 10840 | 0.450 |
Why?
| | Stereotyping | 1 | 2015 | 42 | 0.440 |
Why?
| | Comprehension | 2 | 2014 | 175 | 0.440 |
Why?
| | Prejudice | 1 | 2015 | 59 | 0.440 |
Why?
| | Electrocardiography | 5 | 2017 | 666 | 0.430 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 3 | 0.430 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 69 | 0.430 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 153 | 0.420 |
Why?
| | Ilium | 1 | 2014 | 31 | 0.420 |
Why?
| | Child | 52 | 2025 | 22638 | 0.420 |
Why?
| | Cohort Studies | 14 | 2023 | 6045 | 0.420 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 47 | 0.420 |
Why?
| | Hip Injuries | 1 | 2014 | 14 | 0.410 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 214 | 0.410 |
Why?
| | Blood Pressure | 9 | 2025 | 1761 | 0.410 |
Why?
| | Patient Education as Topic | 4 | 2024 | 769 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2014 | 774 | 0.400 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.400 |
Why?
| | Hip Prosthesis | 1 | 2014 | 42 | 0.400 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 27 | 0.400 |
Why?
| | Materials Testing | 2 | 2017 | 345 | 0.390 |
Why?
| | Patient Satisfaction | 3 | 2018 | 698 | 0.390 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 69 | 0.390 |
Why?
| | Models, Educational | 1 | 2013 | 90 | 0.390 |
Why?
| | Emotions | 2 | 2018 | 555 | 0.380 |
Why?
| | Graft Survival | 6 | 2019 | 508 | 0.380 |
Why?
| | Body Mass Index | 6 | 2025 | 2446 | 0.380 |
Why?
| | Delphi Technique | 9 | 2025 | 347 | 0.380 |
Why?
| | Bone and Bones | 1 | 2016 | 318 | 0.380 |
Why?
| | Recurrence | 15 | 2023 | 1125 | 0.370 |
Why?
| | Liposarcoma | 1 | 2013 | 31 | 0.370 |
Why?
| | Models, Anatomic | 1 | 2013 | 87 | 0.370 |
Why?
| | Postoperative Period | 8 | 2019 | 344 | 0.370 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 130 | 0.370 |
Why?
| | Time-to-Treatment | 1 | 2015 | 257 | 0.370 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 404 | 0.360 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 57 | 0.360 |
Why?
| | Pain Measurement | 9 | 2025 | 567 | 0.360 |
Why?
| | Femur Head | 1 | 2012 | 38 | 0.360 |
Why?
| | Femur Neck | 1 | 2012 | 62 | 0.360 |
Why?
| | Pain Management | 2 | 2014 | 413 | 0.360 |
Why?
| | Acetabulum | 2 | 2014 | 117 | 0.360 |
Why?
| | Surveys and Questionnaires | 10 | 2026 | 6050 | 0.350 |
Why?
| | Universities | 1 | 2014 | 450 | 0.350 |
Why?
| | Nephrectomy | 2 | 2013 | 169 | 0.350 |
Why?
| | Musculoskeletal System | 2 | 2022 | 53 | 0.340 |
Why?
| | Rotation | 3 | 2018 | 122 | 0.340 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 226 | 0.330 |
Why?
| | Age Factors | 11 | 2019 | 3321 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2766 | 0.320 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 44 | 0.320 |
Why?
| | Activities of Daily Living | 4 | 2018 | 438 | 0.310 |
Why?
| | Physical Therapy Modalities | 4 | 2026 | 341 | 0.310 |
Why?
| | Football | 3 | 2017 | 90 | 0.310 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1754 | 0.300 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 189 | 0.300 |
Why?
| | United States | 22 | 2025 | 16041 | 0.300 |
Why?
| | Health Care Surveys | 3 | 2017 | 538 | 0.300 |
Why?
| | Practice Patterns, Physicians' | 4 | 2026 | 1370 | 0.300 |
Why?
| | Random Allocation | 4 | 2019 | 365 | 0.300 |
Why?
| | Joint Prosthesis | 3 | 2015 | 22 | 0.300 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3396 | 0.290 |
Why?
| | Aged, 80 and over | 22 | 2021 | 8351 | 0.290 |
Why?
| | Pilot Projects | 7 | 2021 | 1878 | 0.280 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 124 | 0.280 |
Why?
| | Mass Screening | 2 | 2014 | 1300 | 0.260 |
Why?
| | Patient Readmission | 3 | 2018 | 771 | 0.250 |
Why?
| | Time Factors | 20 | 2026 | 7079 | 0.250 |
Why?
| | Nephrology | 2 | 2024 | 59 | 0.250 |
Why?
| | Joint Diseases | 3 | 2019 | 66 | 0.250 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 43 | 0.240 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 79 | 0.240 |
Why?
| | Arthralgia | 2 | 2025 | 61 | 0.240 |
Why?
| | Patient Positioning | 2 | 2019 | 70 | 0.230 |
Why?
| | Platelet Count | 1 | 2026 | 94 | 0.230 |
Why?
| | Risk Assessment | 9 | 2025 | 3678 | 0.230 |
Why?
| | Attitude of Health Personnel | 2 | 2026 | 1212 | 0.230 |
Why?
| | Synovectomy | 1 | 2025 | 8 | 0.230 |
Why?
| | Infant Mortality | 2 | 2004 | 127 | 0.230 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 37 | 0.230 |
Why?
| | Synovitis | 1 | 2025 | 35 | 0.220 |
Why?
| | Head Injuries, Closed | 1 | 2025 | 49 | 0.220 |
Why?
| | Operative Time | 1 | 2026 | 192 | 0.220 |
Why?
| | Video Recording | 2 | 2024 | 218 | 0.220 |
Why?
| | Electrocoagulation | 4 | 2014 | 35 | 0.220 |
Why?
| | Recovery of Function | 8 | 2026 | 721 | 0.220 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 245 | 0.220 |
Why?
| | Soccer | 1 | 2025 | 40 | 0.220 |
Why?
| | Wound Healing | 3 | 2013 | 348 | 0.220 |
Why?
| | Respiratory Mechanics | 2 | 1995 | 74 | 0.210 |
Why?
| | Humeral Fractures | 2 | 2017 | 46 | 0.210 |
Why?
| | Complement Activation | 2 | 2025 | 412 | 0.210 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 179 | 0.210 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.210 |
Why?
| | Autografts | 3 | 2026 | 56 | 0.210 |
Why?
| | Complement Factor H | 1 | 2025 | 81 | 0.210 |
Why?
| | Reading | 3 | 2014 | 132 | 0.210 |
Why?
| | Catheter Ablation | 5 | 2000 | 355 | 0.200 |
Why?
| | Consensus | 5 | 2025 | 465 | 0.200 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1062 | 0.200 |
Why?
| | Caffeine | 1 | 2024 | 76 | 0.200 |
Why?
| | Patellar Dislocation | 1 | 2023 | 8 | 0.200 |
Why?
| | Synovial Membrane | 1 | 2025 | 130 | 0.200 |
Why?
| | Prehypertension | 1 | 2023 | 27 | 0.200 |
Why?
| | Curriculum | 2 | 2021 | 1074 | 0.200 |
Why?
| | Bone Marrow | 3 | 2023 | 308 | 0.200 |
Why?
| | Prognosis | 13 | 2020 | 4331 | 0.200 |
Why?
| | Prospective Studies | 10 | 2023 | 8087 | 0.200 |
Why?
| | Heart Ventricles | 5 | 2019 | 762 | 0.190 |
Why?
| | Cross-Sectional Studies | 10 | 2026 | 5875 | 0.190 |
Why?
| | Sutures | 3 | 2019 | 66 | 0.190 |
Why?
| | Muscle Strength | 1 | 2026 | 332 | 0.190 |
Why?
| | Urolithiasis | 2 | 2016 | 11 | 0.190 |
Why?
| | Ankle Injuries | 1 | 2023 | 66 | 0.190 |
Why?
| | Debridement | 4 | 2017 | 84 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2026 | 3633 | 0.180 |
Why?
| | Postoperative Care | 4 | 2019 | 292 | 0.180 |
Why?
| | Research Design | 2 | 2018 | 1139 | 0.180 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.180 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.180 |
Why?
| | Urinary Diversion | 2 | 1998 | 14 | 0.170 |
Why?
| | Preoperative Period | 2 | 2018 | 150 | 0.170 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 49 | 0.170 |
Why?
| | Knee Dislocation | 1 | 2021 | 6 | 0.170 |
Why?
| | Biology | 1 | 2022 | 90 | 0.170 |
Why?
| | Arm | 2 | 2019 | 110 | 0.160 |
Why?
| | Verbal Learning | 2 | 2007 | 71 | 0.160 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2218 | 0.160 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 2 | 0.160 |
Why?
| | Comorbidity | 5 | 2018 | 1652 | 0.160 |
Why?
| | Ankle | 2 | 2019 | 69 | 0.160 |
Why?
| | Operating Rooms | 2 | 2024 | 144 | 0.160 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1184 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1323 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 60 | 0.160 |
Why?
| | Marketing of Health Services | 1 | 2020 | 15 | 0.150 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 519 | 0.150 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 8 | 0.150 |
Why?
| | Echocardiography | 4 | 2020 | 645 | 0.150 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 276 | 0.150 |
Why?
| | Osteonecrosis | 1 | 2020 | 23 | 0.150 |
Why?
| | Delayed Graft Function | 2 | 2018 | 54 | 0.150 |
Why?
| | Algorithms | 3 | 2023 | 1843 | 0.150 |
Why?
| | Kidney | 7 | 2016 | 1491 | 0.150 |
Why?
| | Multiple Trauma | 1 | 2021 | 118 | 0.150 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 36 | 0.150 |
Why?
| | Intraoperative Complications | 2 | 2012 | 154 | 0.150 |
Why?
| | Bone Substitutes | 1 | 2019 | 26 | 0.150 |
Why?
| | Kidney Diseases | 3 | 2024 | 427 | 0.140 |
Why?
| | Tensile Strength | 1 | 2019 | 98 | 0.140 |
Why?
| | Workers' Compensation | 1 | 2019 | 28 | 0.140 |
Why?
| | Graft Rejection | 3 | 2018 | 504 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2023 | 385 | 0.140 |
Why?
| | Pudendal Nerve | 1 | 2018 | 1 | 0.140 |
Why?
| | Surgeons | 1 | 2023 | 337 | 0.140 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.140 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1070 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 33 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 824 | 0.130 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 117 | 0.130 |
Why?
| | Thinness | 1 | 2018 | 99 | 0.130 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 14 | 0.130 |
Why?
| | Prosthesis Design | 3 | 2015 | 357 | 0.130 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.130 |
Why?
| | Arthrography | 1 | 2017 | 19 | 0.130 |
Why?
| | Radius | 1 | 2018 | 53 | 0.130 |
Why?
| | Spine | 1 | 2019 | 184 | 0.130 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 298 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 434 | 0.130 |
Why?
| | Child, Preschool | 19 | 2025 | 11888 | 0.130 |
Why?
| | Hospital Charges | 1 | 2017 | 45 | 0.130 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 267 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 314 | 0.130 |
Why?
| | Obesity | 2 | 2018 | 3123 | 0.130 |
Why?
| | Length of Stay | 3 | 2018 | 1342 | 0.130 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 331 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 263 | 0.120 |
Why?
| | Nephrons | 1 | 2016 | 23 | 0.120 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.120 |
Why?
| | Anticoagulants | 1 | 2022 | 743 | 0.120 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 8 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2016 | 14 | 0.120 |
Why?
| | Medical History Taking | 2 | 2014 | 116 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 351 | 0.120 |
Why?
| | Fever | 2 | 2017 | 320 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2023 | 680 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 73 | 0.110 |
Why?
| | Dementia | 1 | 2000 | 322 | 0.110 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 295 | 0.110 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 192 | 0.110 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 743 | 0.110 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1500 | 0.110 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 21 | 0.110 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 10 | 0.110 |
Why?
| | Tendinopathy | 1 | 2015 | 32 | 0.110 |
Why?
| | Lung Diseases | 2 | 2001 | 787 | 0.110 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 582 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 13 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 344 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 91 | 0.110 |
Why?
| | Limb Salvage | 1 | 2015 | 73 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 11 | 0.100 |
Why?
| | Journal Impact Factor | 1 | 2014 | 29 | 0.100 |
Why?
| | Immobilization | 2 | 2026 | 54 | 0.100 |
Why?
| | Fracture Fixation | 1 | 2015 | 80 | 0.100 |
Why?
| | Menstrual Cycle | 1 | 1995 | 145 | 0.100 |
Why?
| | Tachycardia | 4 | 1989 | 58 | 0.100 |
Why?
| | Arthritis | 2 | 2016 | 97 | 0.100 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 25 | 0.100 |
Why?
| | Spinal Stenosis | 1 | 2014 | 31 | 0.100 |
Why?
| | Tourniquets | 1 | 2014 | 34 | 0.100 |
Why?
| | Military Personnel | 2 | 2020 | 715 | 0.100 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 40 | 0.100 |
Why?
| | Running | 1 | 2016 | 234 | 0.100 |
Why?
| | Professional Practice | 1 | 2014 | 58 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2015 | 137 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 340 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 155 | 0.100 |
Why?
| | Malnutrition | 1 | 2015 | 86 | 0.100 |
Why?
| | Pressure | 1 | 2014 | 221 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 417 | 0.100 |
Why?
| | Laser Coagulation | 1 | 2014 | 80 | 0.100 |
Why?
| | Hemostatics | 1 | 2014 | 65 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2025 | 270 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 483 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 99 | 0.100 |
Why?
| | Referral and Consultation | 3 | 2012 | 878 | 0.100 |
Why?
| | Weight-Bearing | 3 | 2026 | 186 | 0.100 |
Why?
| | Canada | 1 | 2014 | 430 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2016 | 514 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 358 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 71 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 78 | 0.090 |
Why?
| | Health Status Disparities | 1 | 2016 | 321 | 0.090 |
Why?
| | Patient Selection | 3 | 2025 | 720 | 0.090 |
Why?
| | Gait | 1 | 2016 | 316 | 0.090 |
Why?
| | Societies, Medical | 2 | 2014 | 901 | 0.090 |
Why?
| | Metals | 1 | 2014 | 137 | 0.090 |
Why?
| | Spirometry | 3 | 2001 | 234 | 0.090 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1531 | 0.090 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 9 | 0.090 |
Why?
| | Incidental Findings | 1 | 2013 | 81 | 0.090 |
Why?
| | Pneumonia | 1 | 2018 | 633 | 0.090 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 344 | 0.090 |
Why?
| | Severity of Illness Index | 6 | 2016 | 2910 | 0.090 |
Why?
| | Ultrasonography | 3 | 2022 | 788 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 14 | 0.090 |
Why?
| | Watchful Waiting | 1 | 2012 | 90 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 102 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 209 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1700 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 16 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 59 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 60 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 229 | 0.080 |
Why?
| | Registries | 2 | 2018 | 2382 | 0.080 |
Why?
| | Smoking | 1 | 2018 | 1478 | 0.080 |
Why?
| | Diagnostic Errors | 1 | 2012 | 178 | 0.080 |
Why?
| | Educational Measurement | 1 | 2014 | 329 | 0.080 |
Why?
| | Policy Making | 1 | 2011 | 83 | 0.080 |
Why?
| | Proteinuria | 3 | 2007 | 103 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2015 | 489 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2012 | 297 | 0.080 |
Why?
| | Tooth | 2 | 1990 | 47 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 66 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 131 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 176 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 154 | 0.070 |
Why?
| | Bicuspid | 2 | 1988 | 14 | 0.070 |
Why?
| | Lead | 1 | 1990 | 71 | 0.070 |
Why?
| | Upper Extremity | 1 | 2010 | 114 | 0.070 |
Why?
| | Molar | 2 | 1988 | 47 | 0.070 |
Why?
| | Cancer Vaccines | 1 | 2010 | 161 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2009 | 182 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 168 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 2 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 341 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 5 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 431 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 232 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 668 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 42 | 0.070 |
Why?
| | Urography | 2 | 1998 | 19 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 177 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 44 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 410 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 3 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1136 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Systole | 2 | 2019 | 179 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1325 | 0.060 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 108 | 0.060 |
Why?
| | Dental Caries | 2 | 1988 | 173 | 0.060 |
Why?
| | Ginkgo biloba | 1 | 2007 | 10 | 0.060 |
Why?
| | Creatinine | 3 | 2008 | 511 | 0.060 |
Why?
| | Logistic Models | 3 | 2015 | 2112 | 0.060 |
Why?
| | Hospitalization | 3 | 2016 | 2468 | 0.060 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 211 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 359 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 641 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 176 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 67 | 0.060 |
Why?
| | Urine | 1 | 2006 | 63 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2025 | 35 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 362 | 0.060 |
Why?
| | Atmosphere Exposure Chambers | 2 | 1995 | 6 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 11 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 76 | 0.050 |
Why?
| | Plant Extracts | 1 | 2007 | 191 | 0.050 |
Why?
| | Return to Work | 2 | 2015 | 21 | 0.050 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 10 | 0.050 |
Why?
| | Shoulder Pain | 2 | 2018 | 37 | 0.050 |
Why?
| | Sleep | 2 | 2022 | 896 | 0.050 |
Why?
| | Lung | 2 | 1995 | 4119 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 224 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 994 | 0.050 |
Why?
| | Probability | 2 | 2006 | 308 | 0.050 |
Why?
| | Vital Capacity | 2 | 1995 | 293 | 0.050 |
Why?
| | Leukocytes | 1 | 2006 | 301 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 129 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 39 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 27 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 822 | 0.050 |
Why?
| | Forced Expiratory Volume | 2 | 1995 | 451 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 118 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 3 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 44 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 547 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 82 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 3 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 847 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 38 | 0.050 |
Why?
| | New England | 1 | 2003 | 37 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 109 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 147 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 82 | 0.050 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 220 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 160 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 319 | 0.050 |
Why?
| | Injections | 1 | 2023 | 199 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 9 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 184 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 32 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 71 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 3 | 0.040 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.040 |
Why?
| | Environmental Exposure | 2 | 2001 | 578 | 0.040 |
Why?
| | American Heart Association | 1 | 2023 | 363 | 0.040 |
Why?
| | Emergencies | 1 | 2023 | 173 | 0.040 |
Why?
| | Nitrites | 1 | 2002 | 85 | 0.040 |
Why?
| | Forecasting | 1 | 2023 | 386 | 0.040 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 60 | 0.040 |
Why?
| | Infant | 8 | 2013 | 10093 | 0.040 |
Why?
| | Thiazoles | 1 | 2002 | 139 | 0.040 |
Why?
| | Airway Resistance | 1 | 2001 | 38 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1293 | 0.040 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 57 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2016 | 328 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 210 | 0.040 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 165 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1992 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 23 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 190 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 207 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2026 | 486 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 207 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 130 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 7 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 59 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 228 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 341 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 133 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 30 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 530 | 0.040 |
Why?
| | Reference Values | 3 | 2000 | 787 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 42 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 34 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 24 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1286 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 2097 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 28 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 244 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 246 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 15 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 466 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 123 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1122 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 2078 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 203 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 3210 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 18 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 489 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 3187 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 147 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 376 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 194 | 0.030 |
Why?
| | Consumer Product Safety | 1 | 2020 | 80 | 0.030 |
Why?
| | Proteoglycans | 1 | 2019 | 111 | 0.030 |
Why?
| | Serum | 1 | 2019 | 58 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 124 | 0.030 |
Why?
| | Research Subjects | 1 | 2018 | 42 | 0.030 |
Why?
| | Calcium | 1 | 2004 | 1181 | 0.030 |
Why?
| | Depression | 1 | 2008 | 1566 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 248 | 0.030 |
Why?
| | Thigh | 1 | 2018 | 48 | 0.030 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.030 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.030 |
Why?
| | ROC Curve | 1 | 2000 | 613 | 0.030 |
Why?
| | Cystoscopy | 1 | 1998 | 21 | 0.030 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 18 | 0.030 |
Why?
| | Demography | 1 | 2018 | 274 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2018 | 63 | 0.030 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 56 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 31 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 58 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 32 | 0.030 |
Why?
| | Torque | 1 | 2017 | 82 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 34 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4329 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 51 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 4 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1318 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2783 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 14 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 171 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 164 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1051 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 718 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 543 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 306 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 89 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1824 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 398 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 159 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 544 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1247 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 44 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 143 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1114 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 316 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1995 | 5 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 18 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 80 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 927 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 88 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2357 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 132 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 151 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 3 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6449 | 0.030 |
Why?
| | Decision Making | 2 | 2011 | 987 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 39 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 2 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 90 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 289 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 144 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 227 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 121 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 55 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 17 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 12 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 68 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 315 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 944 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 466 | 0.020 |
Why?
| | Biopsy | 3 | 2007 | 1073 | 0.020 |
Why?
| | Pregnancy | 2 | 2004 | 7217 | 0.020 |
Why?
| | Urban Population | 2 | 1990 | 496 | 0.020 |
Why?
| | Polymers | 1 | 2017 | 484 | 0.020 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 63 | 0.020 |
Why?
| | Outpatients | 1 | 2017 | 437 | 0.020 |
Why?
| | Penile Diseases | 1 | 1993 | 5 | 0.020 |
Why?
| | Histoplasmosis | 1 | 1993 | 15 | 0.020 |
Why?
| | Wounds, Penetrating | 1 | 1994 | 71 | 0.020 |
Why?
| | Caregivers | 1 | 2022 | 1079 | 0.020 |
Why?
| | Acute Disease | 3 | 2015 | 1033 | 0.020 |
Why?
| | Biological Evolution | 1 | 1997 | 471 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2013 | 60 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1372 | 0.020 |
Why?
| | Exercise | 2 | 1995 | 2206 | 0.020 |
Why?
| | Skull | 1 | 1994 | 162 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 538 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 649 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 507 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 104 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 169 | 0.020 |
Why?
| | France | 2 | 1990 | 40 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 634 | 0.020 |
Why?
| | North America | 1 | 2013 | 299 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 209 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 271 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 24 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 372 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1034 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 10 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 54 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1581 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 56 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 23 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 8 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 15 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 103 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 907 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Animals | 6 | 2019 | 38030 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 65 | 0.020 |
Why?
| | Prefrontal Cortex | 1 | 1994 | 338 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1133 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 55 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 182 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 647 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 34 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 91 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 14 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 36 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 1037 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 160 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 386 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 60 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2623 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 131 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1996 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 283 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 241 | 0.020 |
Why?
| | New York | 1 | 2009 | 127 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 111 | 0.020 |
Why?
| | Brain Injuries | 1 | 1994 | 499 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1041 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 389 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 53 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 41 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 11 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 914 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 19 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 144 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 399 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 477 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 120 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 375 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 134 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 40 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 109 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 47 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 190 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 74 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 573 | 0.010 |
Why?
| | Metabolic Diseases | 1 | 2007 | 114 | 0.010 |
Why?
| | Angiography | 2 | 2000 | 206 | 0.010 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2079 | 0.010 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.010 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 339 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 28 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 80 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 31 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 26 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 419 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 673 | 0.010 |
Why?
| | Memory | 1 | 2007 | 298 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 900 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 17 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2915 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2018 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 147 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 108 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 257 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 164 | 0.010 |
Why?
| | Attention | 1 | 2007 | 459 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 380 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3538 | 0.010 |
Why?
| | Learning | 1 | 2007 | 446 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 191 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 14 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2007 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 956 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 10 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 138 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 536 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 39 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 90 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 169 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 168 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 242 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 460 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1269 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 455 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 777 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 651 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 58 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 122 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2852 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 17 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 17 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 112 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 88 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 62 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 257 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 585 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 295 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 187 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1209 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 495 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 542 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 339 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 505 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 108 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 96 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 612 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 950 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 749 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 5 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 151 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 5 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 611 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 801 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 771 | 0.010 |
Why?
| | Explosions | 1 | 1994 | 14 | 0.010 |
Why?
| | History, 19th Century | 1 | 1994 | 63 | 0.010 |
Why?
| | Accidents, Occupational | 1 | 1994 | 18 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 519 | 0.010 |
Why?
| | Penis | 1 | 1993 | 33 | 0.010 |
Why?
| | New York City | 1 | 1993 | 87 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 633 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 34 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 71 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 5 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 384 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 38 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 135 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 43 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 199 | 0.000 |
Why?
| | Nitroprusside | 1 | 1990 | 70 | 0.000 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 82 | 0.000 |
Why?
| | Income | 1 | 1991 | 205 | 0.000 |
Why?
| | Chromatography, Gel | 1 | 1990 | 131 | 0.000 |
Why?
| | Immunoblotting | 1 | 1990 | 294 | 0.000 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 326 | 0.000 |
Why?
| | Solubility | 1 | 1990 | 240 | 0.000 |
Why?
| | Disease Progression | 1 | 1997 | 2857 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 48 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 144 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 758 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 83 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 231 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 938 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 239 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 51 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 75 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 10 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 22 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 9 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 62 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1800 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 11 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 627 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 46 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 125 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 228 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 179 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 638 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 711 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5574 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 23 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 3 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 7 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 17 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 23 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 20 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 115 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 104 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1935 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 239 | 0.000 |
Why?
| | Shock | 1 | 1972 | 99 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 246 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 314 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 387 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 634 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 996 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 824 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 830 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|